|
Cardiovascular Disease/ Myocardial Infarction
Citations 471-480 of 1004 total displayed.
|
Past content
(since Feb 1998):
|
- Letters
Risks and Benefits of Fish Intake
- Tomi-Pekka Tuomainen; Sari Voutilainen; Staffan Skerfving; Jukka T. Salonen
JAMA 2007; 297: 585-a-586-a.
[Extract]
[Full text]
[PDF]
- Letters
Risks and Benefits of Fish Intake
- Michel Lucas; William S. Harris
JAMA 2007; 297: 585.
[Extract]
[Full text]
[PDF]
- Letters
Cyclooxygenase Inhibitors and Cardiovascular Risk
- Frank Andersohn; Samy Suissa; Edeltraut Garbe
JAMA 2007; 297: 586-a-587-a.
[Extract]
[Full text]
[PDF]
- Letters
Risks and Benefits of Fish Intake—Reply
- Dariush Mozaffarian; Eric Rimm
JAMA 2007; 297: 586.
[Extract]
[Full text]
[PDF]
- Letters
Cyclooxygenase Inhibitors and Cardiovascular Risk—Reply
- David Henry; Patricia McGettigan
JAMA 2007; 297: 587-588.
[Extract]
[Full text]
[PDF]
- Original Contributions
Routine Upstream Initiation vs Deferred Selective Use of Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes: The ACUITY Timing Trial
- Gregg W. Stone; Michel E. Bertrand; Jeffrey W. Moses; E. Magnus Ohman; A. Michael Lincoff; James H. Ware; Stuart J. Pocock; Brent T. McLaurin; David A. Cox; M. Zubair Jafar; Harish Chandna; Franz Hartmann; Franz Leisch; Ruth H. Strasser; Martin Desaga; Thomas D. Stuckey; Richard B. Zelman; Ira H. Lieber; David J. Cohen; Roxana Mehran; Harvey D. White; for the ACUITY Investigators
JAMA 2007; 297: 591-602.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Reduction of Iron Stores and Cardiovascular Outcomes in Patients With Peripheral Arterial Disease: A Randomized Controlled Trial
- Leo R. Zacharski; Bruce K. Chow; Paula S. Howes; Galina Shamayeva; John A. Baron; Ronald L. Dalman; David J. Malenka; C. Keith Ozaki; Philip W. Lavori
JAMA 2007; 297: 603-610.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women: The Reynolds Risk Score
- Paul M Ridker; Julie E. Buring; Nader Rifai; Nancy R. Cook
JAMA 2007; 297: 611-619.
[Abstract]
[Full text]
[PDF]
[ JAMA News Video ] [ Author in the Room Audio ]
- Editorials
Optimal Timing for Use of Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes: Questions, Answers, and More Questions
- Kenneth W. Mahaffey; Robert A. Harrington
JAMA 2007; 297: 636-639.
[Extract]
[Full text]
[PDF]
- Editorials
The Iron-Heart Hypothesis: Search for the Ironclad Evidence
- Frank B. Hu
JAMA 2007; 297: 639-641.
[Extract]
[Full text]
[PDF]
|
|
